The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
Open accessAbstract
Several studies have reported elevated circulating homocyst(e)ine levels in subjects with cerebral atherosclerosis. We assessed prospectively whether high plasma levels of homocyst(e)ine affect risk of ischemic stroke and evaluated whether high blood pressure modifies any such effect. The study sample was drawn from the Physicians' Health Study, a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene in 22,071 US male physicians. A total of 14,916 subjects 40 to 84 years old with no prior history of stroke, transient ischemic attack, or myocardial infarction provided blood samples at baseline and were followed for 5 years, with 99.7% morbidity and 100% mortality follow-up. Using a nested case-control design, we assayed homocyst(e)ine in samples from 109 subjects who subsequently developed ischemic stroke and 427 control subjects. The mean plasma concentration of homocyst(e)ine was slightly higher in subjects with stroke (11.1 +/- 4.0 [+/- SD] nmol/mL) than in control subjects (10.6 +/- 3.4 nmol/mL), but the difference was not statistically significant (P = .12). The crude odds ratio of ischemic stroke for subjects in the upper 20% (> 12.7 nmol/mL) compared with those in the bottom 80% of homocyst(e)ine levels was 1.4 (95% confidence interval, 0.8 to 2.2). The odds ratio was 1.2 (95% confidence interval, 0.7 to 2.0) after controlling for several risk factors and other potential confounders. In subgroup analyses, elevated homocyst(e)ine levels appeared to be more strongly predictive of ischemic stroke in normotensive subjects and in men 60 years or younger. Although not statistically significant, in these subgroups increases in risks of 100% and 70%, respectively, were observed for men in the upper 20% of homocyst(e)ine values. In this study, the data were compatible with a small but nonsignificant association between elevated plasma homocyst(e)ine and risk of ischemic stroke. However, since the sample size is small and the confidence intervals are wide, either no association or a moderate increase in risk cannot be excluded, particularly in subgroups otherwise at low risk, eg, younger men and those with normal blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Self-citationA prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163
Self-citationEndothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
Starkebaum, G., & Harlan, J. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112442 · Cited by 822
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Ueland, P. M., & Refsum, H. (1989) · PubMed · Cited by 688
Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
Malinow, M. R., Kang, S. S., Taylor, L. M., Wong, P. W., Coull, B., Inahara, T., Mukerjee, D., Sexton, G., & Upson, B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1180 · Cited by 501
Self-citationVitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
Ubbink, J., Vermaak, W., van der Merwe, A., & Becker, P. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.1.47 · Cited by 461
The National Survey of Stroke. Clinical findings.
Walker, A., Robins, M., & Weinfeld, F. D. (1981) · PubMed · Cited by 460
Cited by
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Plasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.1997.03540460039030 · Cited by 1,738
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Self-citationHomocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Perry, I. J., Morris, R. W., Ebrahim, S. B., Shaper, A. G., Refsum, H., & Ueland, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92407-8 · Cited by 883
Mosca, L., Manson, J. E., Sutherland, S. E., Langer, R. D., Manolio, T., & Barrett-Connor, E. (1997) · Circulation · doi:10.1161/01.cir.96.7.2468 · Cited by 736
Malinow, M. R., Bostom, A. G., & Krauss, R. M. (1999) · Circulation · doi:10.1161/01.cir.99.1.178 · Cited by 586
Self-citationThe controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Bostom, A. G., Rosenberg, I. H., Silbershatz, H., Jacques, P. F., Selhub, J., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00006 · Cited by 438
Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
Petri, M., Roubenoff, R., Dallal, G. E., Nadeau, M. R., Selhub, J., & Rosenberg, I. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03032-2 · Cited by 419
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.277.22.1775 · Cited by 405
Wald, N. J., Watt, H. C., Law, M. R., Weir, D. G., McPartlin, J., & Scott, J. M. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.862 · Cited by 369
Hoogeveen, E. K., Kostense, P. J., Beks, P. J., Mackaay, A. J. C., Jakobs, C., Bouter, L. M., Heine, R. J., & Stehouwer, C. D. A. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.1.133 · Cited by 362
Hyperhomocysteinemia, Atherosclerosis and Thrombosis
Cattaneo, M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614438 · Cited by 362
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Evans, R. W., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1947 · Cited by 342
Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism
Ridker, P. M., Hennekens, C. H., Selhub, J., Miletich, J. P., Malinow, M. R., & Stampfer, M. J. (1997) · Circulation · doi:10.1161/01.cir.95.7.1777 · Cited by 338
Self-citationEvaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ridker, P. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00018 · Cited by 323
Vermeulen, E., Stehouwer, C., Twisk, J., van den Berg, M., de Jong, S., Mackaay, A., van Campen, C., Visser, F., Jakobs, C., Bulterijs, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)07391-2 · Cited by 322
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Christen, W. G., Ajani, U. A., Glynn, R. J., & Hennekens, C. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.422 · Cited by 304
Self-citationArruda, V. R., von Zuben, P. M., Chiaparini, L. C., Annichino-Bizzacchi, J. M., & Costa, F. F. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656059 · Cited by 296
Homocysteine and cardiovascular disease: a review of the evidence
Wierzbicki, A. S. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.033 · Cited by 287
High Homocysteine Levels Are Independently Related to Isolated Systolic Hypertension in Older Adults
Sutton-Tyrrell, K., Bostom, A., Selhub, J., & Zeigler-Johnson, C. (1997) · Circulation · doi:10.1161/01.cir.96.6.1745 · Cited by 280
Do age-related macular degeneration and cardiovascular disease share common antecedents?
Snow, K. K., & Seddon, J. M. (1999) · Ophthalmic Epidemiology · doi:10.1076/opep.6.2.125.1558 · Cited by 274
Hoogeveen, E. K., Kostense, P. J., Jakobs, C., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2000) · Circulation · doi:10.1161/01.cir.101.13.1506 · Cited by 273
Impaired Homocysteine Metabolism and Atherothrombotic Disease
Durand, P., Prost, M., Loreau, N., Lussier-Cacan, S., & Blache, D. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780275 · Cited by 261
Bots, M. L., Launer, L. J., Lindemans, J., Hoes, A. W., Hofman, A., Witteman, J. C. M., Koudstaal, P. J., & Grobbee, D. E. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.38 · Cited by 260
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
Evans, J. R., & Lawrenson, J. G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000253.pub4 · Cited by 257
Total homocysteine and cardiovascular disease
Nygård, O., Vollset, S. E., Refsum, H., Brattström, L., & Ueland, P. M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00512.x · Cited by 256
Harmon, D. L., Shields, D. C., Woodside, J. V., McMaster, D., Yarnell, J. W. G., Young, I. S., Peng, K., Shane, B., Evans, A. E., & Whitehead, A. S. (1999) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(199911)17:4<298::aid-gepi5>3.0.co;2-v · Cited by 256
Homocysteine and Risk of Cardiovascular Disease Among Postmenopausal Women
Ridker, P. M. (1999) · JAMA · doi:10.1001/jama.281.19.1817 · Cited by 253
Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136
Prospective Studies of Homocysteine and Cardiovascular Disease
Verhoef, P., & Stampfer, M. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1995.tb01478.x · Cited by 58
Self-citationSato, Y., Honda, Y., Iwamoto, J., Kanoko, T., & Satoh, K. (2005) · JAMA · doi:10.1001/jama.293.9.1082 · Cited by 2
“Therefore, there are close relationships between plasma homocysteine and cobalamin and folate.(8,9,24-26) We previously demonstrated a reduction in plasma homocysteine levels by combination therapy with folate and vitamin B12 in patients with ischemic stroke.”
BackgroundRetracted
Metadata
- Authors
- Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Willett, W. C., & Stampfer, M. J.
- Venue
- Stroke
- Published
- 1994-10
- Volume
- 25
- Issue
- 10
- Pages
- 1924-1930
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2152148859
- Cited by
- 379
- References
- 25
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.